{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:37:24Z","timestamp":1772843844525,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1002\/jps.23249","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T21:02:55Z","timestamp":1341608575000},"page":"3739-3752","source":"Crossref","is-referenced-by-count":80,"title":["Development and Characterization of a Novel Nystatin\u2010Loaded Nanoemulsion for the Buccal Treatment of Candidosis: Ultrastructural Effects and Release Studies"],"prefix":"10.1016","volume":"101","author":[{"given":"Francisco Fern\u00e1ndez","family":"Campos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Calpena Campmany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gelen Rodr\u00edguez","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga L\u00f3pez","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Clares","family":"Naveros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23249_bb0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1517\/17425247.2010.525230","article-title":"Topical delivery of antifungal agents","volume":"7","author":"Kaur","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1002\/jps.23249_bb0015","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1128\/AAC.48.12.4808-4812.2004","article-title":"Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.","volume":"48","author":"Offmer","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.23249_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11046-009-9271-z","article-title":"Nystatin\u2013intralipid preparation: Characterization and in vitro activity against yeasts and molds","author":"Semis","year":"2010","journal-title":"Mycopathologia"},{"key":"10.1002\/jps.23249_bb0025","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1128\/AAC.42.6.1412","article-title":"Comparison of in vitro antifungal activities of free and liposome\u2010encapsulated nystatin with those of four amphotericin B formulations","volume":"42","author":"Johnson","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.23249_bb0030","series-title":"Fungal infection. Diagnosis and management","first-page":"29","article-title":"Antifungal drugs","author":"Richardson","year":"2003"},{"key":"10.1002\/jps.23249_bb0035","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3109\/03639040903384729","article-title":"Oral sustained release nystatin tablets for the treatment of oral candidosis: Formulation development and validation of UV spectrophotometric analytical methodology for content determination","volume":"36","author":"de Aguiar","year":"2010","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.23249_bb0040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.clindermatol.2009.12.014","article-title":"Candidosis, a new challenge","volume":"28","author":"Lopez\u2010Martinez","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1002\/jps.23249_bb0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/13693780701218689","article-title":"Nosocomial fungal infections: Epidemiology, diagnosis and treatment","volume":"45","author":"Perlroth","year":"2007","journal-title":"Med Mycol"},{"key":"10.1002\/jps.23249_bb0050","doi-asserted-by":"crossref","first-page":"S6e1","DOI":"10.1016\/j.tripleo.2006.11.003","article-title":"Use of prophylactic antifungals in the immunocompromised host","volume":"103","author":"Ship","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1002\/jps.23249_bb0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1034\/j.1399-302X.1999.140605.x","article-title":"Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin","volume":"14","author":"Ellepola","year":"1999","journal-title":"Oral Microbiol Immunol"},{"key":"10.1002\/jps.23249_bb0060","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1517\/13543784.13.8.903","article-title":"Novel modes of antifungical drug administration","volume":"13","author":"Arthur","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1002\/jps.23249_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10266-009-0118-3","article-title":"Antifungal drug resistance of oral fungi","volume":"98","author":"Niimi","year":"2010","journal-title":"Odontology"},{"key":"10.1002\/jps.23249_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00232-010-9304-z","article-title":"Effect of membrane structure on the action of polyenes: I. Nystatin action in cholesterol and ergosterol\u2010containing membranes","volume":"237","author":"Recamier","year":"2010","journal-title":"J Membr Biol"},{"key":"10.1002\/jps.23249_bb0075","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbamem.2006.03.008","article-title":"Nystatin\u2010induced lipid vesicles permeabilization is strongly dependent on sterol structure","volume":"1758","author":"Silva","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/jps.23249_bb0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2003.11.003","article-title":"Effects of pluronic block copolymers on the aggregation state of nystatin","volume":"95","author":"Croy","year":"2004","journal-title":"J Control Release"},{"key":"10.1002\/jps.23249_bb0085","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jps.21513","article-title":"Novel mucoadhesive extended release tablets for treatment of oral candidosis: \u201cIn vivo\u201d evaluation of the pharmaceutical performance","volume":"98","author":"Llabot","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23249_bb0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jconrel.2004.05.002","article-title":"Chitosan delivery system for the treatment of oral mucositis: In vitro and in vivo studies","volume":"98","author":"Aksungur","year":"2004","journal-title":"J Control Release"},{"key":"10.1002\/jps.23249_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2006.12.001","article-title":"Design of novel antifungal mucoadhesive films. Part II. Formulation and in vitro biopharmaceutical evaluation","volume":"336","author":"Llabot","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23249_bb0100","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/AAC.44.10.2887-2890.2000","article-title":"In vitro pharmacodynamic characteristics of nystatin including time\u2010kill and postantifungal effect.","volume":"44","author":"Gunderson","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.23249_bb0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cocis.2005.06.004","article-title":"Nano\u2010emulsions","volume":"10","author":"Solans","year":"2005","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"10.1002\/jps.23249_bb0110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0975-8453.59509","article-title":"Nanoemulsion: A pharmaceutical review","volume":"1","author":"Shah","year":"2010","journal-title":"Sys Rev Pharm"},{"key":"10.1002\/jps.23249_bb0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2478\/v10007-007-0025-5","article-title":"Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib","volume":"57","author":"Baboota","year":"2007","journal-title":"Acta Pharm"},{"key":"10.1002\/jps.23249_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cis.2006.05.014","article-title":"Microemulsions as transdermal drug delivery vehicles","volume":"123\u2013126","author":"Kogan","year":"2006","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1002\/jps.23249_bb0125","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1469-0691.2007.01935.x","article-title":"EUCAST definitive document EDef 7.1: Method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts","volume":"14","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1002\/jps.23249_bb0130","series-title":"Manual of clinical microbiology","first-page":"1880","author":"Murray","year":"2003"},{"key":"10.1002\/jps.23249_bb0135","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1016\/j.biomaterials.2003.10.095","article-title":"Thermally responsive core\u2013shell nanoparticles self\u2010assembled from cholesterylend\u2010capped and grafted polyacrylamides: Drug incorporation and in vitro release","volume":"25","author":"Chaw","year":"2004","journal-title":"Biomaterials"},{"key":"10.1002\/jps.23249_bb0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23249_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01117450","article-title":"Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.23249_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2006.04.012","article-title":"Buccal bioadhesive drug delivery. A promising option for orally less efficient drugs","volume":"114","author":"Sudhakar","year":"2006","journal-title":"J Control Release"},{"key":"10.1002\/jps.23249_bb0155","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jps.22271","article-title":"Potential use of nanostructured lipid nanocarriers for topical delivery of flurbiprofen","volume":"100","author":"Gonzalez\u2010Mira","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23249_bb0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2818.1997.2200779.x","article-title":"Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy","volume":"187","author":"Vanden Berge","year":"1997","journal-title":"J Microsc"},{"key":"10.1002\/jps.23249_bb0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","article-title":"Microemulsion\u2010based media as novel drug delivery systems","volume":"45","author":"Lawrence","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23249_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2003.10.037","article-title":"Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug","volume":"27","author":"Djordjevic","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23249_bb0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1011067300397","article-title":"Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysis","volume":"18","author":"Kreilgaard","year":"2001","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23249_bb0180","unstructured":"Gattefoss\u00e9 SA. 1994. Microemulsions: Formulation guide, publication No PF9225 A. Saint\u2010Priest Cedex, France: Gattefoss\u00e9."},{"key":"10.1002\/jps.23249_bb0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cis.2003.10.026","article-title":"Nanoemulsions: A new vehicle for skincare products","volume":"108","author":"Sonneville\u2010Aubrun","year":"2004","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1002\/jps.23249_bb0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.colsurfb.2009.03.007","article-title":"Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent","volume":"72","author":"Celia","year":"2009","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1002\/jps.23249_bb0195","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jconrel.2004.01.005","article-title":"Preparation, characterization and in vitro release kinetics of clozapina solid lipid nanoparticles","volume":"95","author":"Venkateswarlu","year":"2004","journal-title":"J Control Release"},{"key":"10.1002\/jps.23249_bb0200","first-page":"110","article-title":"Analysis of Fickian and non\u2010Fickian drug release from polymers","volume":"60","author":"Peppas","year":"1985","journal-title":"Pharm Acta Helv"},{"key":"10.1002\/jps.23249_bb0205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/17425241003602259","article-title":"Drug release kinetics and transport mechanisms of non\u2010degradable and degradable polymeric delivery systems","volume":"7","author":"Fu","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1002\/jps.23249_bb0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00112-0","article-title":"Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)","volume":"48","author":"Siepmann","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.23249_bb0215","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejps.2009.03.005","article-title":"Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin","volume":"37","author":"Moreno","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23249_bb0220","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/jps.10505","article-title":"The effects of various in vitro conditions on the permeability characteristics of the buccal mucosa","volume":"92","author":"Nicolazzo","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23249_bb0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejpb.2008.08.016","article-title":"In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery","volume":"71","author":"Figueiras","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.23249_bb0230","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1128\/AAC.44.4.950-957.2000","article-title":"Compartmental pharmacokinetics and tissue distribution of multilamellar liposomal nystatin in rabbits","volume":"44","author":"Groll","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.23249_bb0235","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0378-5173(94)90098-1","article-title":"Effect of d\u2010limonene on the transdermal permeation of nifedipine and domperidone","volume":"103","author":"Calpena","year":"1994","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.23249_bb0240","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2011.01.027","article-title":"Advances in oral transmucosal drug delivery","volume":"153","author":"Patel","year":"2011","journal-title":"J Control Release"},{"key":"10.1002\/jps.23249_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oxfordjournals.jncimonographs.a003443","article-title":"Biology of oral mucosa and esophagus","volume":"29","author":"Squier","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/jps.23249_bb0250","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0928-0987(99)00075-5","article-title":"Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations","volume":"9","author":"Muraa","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23249_bb0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0939-6411(01)00215-6","article-title":"Influence of Transcutol\u00ae CG on the skin accumulation and transdermal permeation of ultraviolet absorbers","volume":"53","author":"Godwin","year":"2002","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.23249_bb0260","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archderm.138.7.949","article-title":"Ultrastructural aspects of mucosas in endemic pemphigus foliaceus","volume":"138","author":"Guedes","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1002\/jps.23249_bb0265","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1021\/mp9000734","article-title":"Lipid nanostructures: Self\u2010assembly and effect on skin properties","volume":"6","author":"Barbosa\u2010Barros","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1002\/jps.23249_bb0270","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/jid.1966.180","article-title":"Electron microscopic studies of the normal human buccal mucosa","volume":"47","author":"Hashimoto","year":"1996","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915313848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915313848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T17:16:05Z","timestamp":1561914965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915313848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0022354915313848"],"URL":"https:\/\/doi.org\/10.1002\/jps.23249","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}